New gel injection aims to smooth out acne scars

NCT ID NCT07207369

Recruiting now Symptom relief Sponsor: AbbVie Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests an injectable gel called ELAPR002f to see if it safely reduces atrophic acne scars (indented scars) on the cheeks. About 395 adults with moderate to severe scarring will receive either the gel or a saline placebo over 2 months, then be followed for a year. The goal is to measure scar improvement and any side effects.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ACNE SCARS

Contacts and locations

Locations

Advanced Research Associates - Glendale /ID# 254961
RECRUITING

Glendale, Arizona, 85308, United States
Aesthetic Center at Woodholme /ID# 256197
RECRUITING

Baltimore, Maryland, 21208-6391, United States
Austin Institute for Clinical Research - Pflugerville /ID# 256200
RECRUITING

Pflugerville, Texas, 78660, United States
DMR Research PLLC /ID# 256199
RECRUITING

Westport, Connecticut, 06880, United States
Hamilton Research, LLC /ID# 256925
RECRUITING

Alpharetta, Georgia, 30022, United States
Marcus Facial Plastic Surgery /ID# 275880
RECRUITING

Redondo Beach, California, 90277, United States
Pacific Clinical Innovations /ID# 256185
RECRUITING

Vista, California, 92083-6030, United States
SkinDC /ID# 254962
RECRUITING

Arlington, Virginia, 22209, United States
The Center for Dermatology Cosmetics & Laser Surgery /ID# 256182
RECRUITING

Mount Kisco, New York, 10549-3028, United States
Wilmington Dermatology Center /ID# 256192
RECRUITING

Wilmington, North Carolina, 28403, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.